New Ozempic pill now available in the U.S.

• Novo Nordisk introduced its rebranded oral semaglutide tablet, Rybelsus, will quickly be obtainable because the ‘Ozempic tablet’ following a formulation change.
• The smaller, reformulated tablet shall be obtainable in numerous dosages than the Rybelsus tablet, with Novo Nordisk stating it offers the identical efficacy and security profile as the unique formulation.
• The healthcare firm additionally states that the Ozempic tablet shall be obtainable nationwide by means of pharmacies, telehealth, and mail-order providers.
• Pricing is predicted to differ by protection, with insured sufferers doubtlessly paying $25 for as much as 3 months, whereas self-pay choices are estimated between $149 and $299 per thirty days relying on dose.

Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist that mimics a hormone to extend insulin secretion, gradual gastric emptying, and scale back urge for food.

The treatment has Meals and Drug Administration (FDA) approval for serving to with long-term weight administration and treating type 2 diabetes.

For many individuals, semaglutide is healthier often called the injectable drug Ozempic. Nonetheless, many might not be conscious that semaglutide has been obtainable in oral type because it was accepted by the FDA in 2019.

After beforehand asserting a rebrand and reformulation to Rybelsus in February 2026 to make the remedy extra simply recognizable and bioavailable, Novo Nordisk introduced that the “Ozempic pill” shall be obtainable for adults with sort 2 diabetes in the US beginning Monday, Might 4, 2026.

Highlighting that the oral tablet might help enhance blood glucose management alongside weight loss program and train, whereas additionally lowering main cardiovascular occasions in adults with sort 2 diabetes at elevated threat, the pharmaceutical firm provides that the tablet shall be obtainable by means of 70,000+ U.S. pharmacies nationwide and choose telehealth suppliers.

The oral tablet was designed to assist enhance blood glucose management alongside weight loss program and train, whereas additionally providing extra cardiometabolic advantages in sure excessive threat sufferers.

Now rebranded because the Ozempic tablet, the up to date formulation is accessible in numerous strengths of 1.5 mg, 4 mg, and 9 mg. Within the press launch, Novo Nordisk states that the Ozempic tablet formulation is extra bioavailable and works equally to the Rybelsus tablets, providing the identical efficacy and security profile as the unique formulation, however in a smaller tablet.

The pharmaceutical firm provides that folks ought to take the brand new formulation the same way as earlier than, in order that individuals who had been taking 3 mg ought to now take 1.5 mg, and so forth.

Whereas each injectable Ozempic and oral Rybelsus include semaglutide and have approval for sort 2 diabetes, Novo Nordisk recommend the model identify Ozempic is extra synonymous with GLP-1 medicines, therefore the rename.

“Whereas the oral type of semaglutide has been obtainable for years as Rybelsus, the Ozempic branding is extra well known, which can result in elevated affected person requests,” Mir Ali, MD, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Heart at Orange Coast Medical Heart in Fountain Valley, CA, advised Medical Information At present.

“Moreover, as a result of the oral type has an extended shelf life, it might supply logistical benefits for sure prescribing patterns,” Ali defined.

The selection between oral and injectable formulations is usually all the way down to particular person components and preferences. It’s advisable for an individual to debate choices with their healthcare skilled.

Typically, analysis means that injectable semaglutide achieves significantly larger HbA1c reductions in comparison with oral kinds in these with sort 2 diabetes.

Moreover, whereas the each day oral type could also be preferable to weekly injections, analysis means that adversarial occasions happen more frequently with oral semaglutide.

Chatting with MNT, Ali famous the potential benefits and downsides of oral GLP-1 medicines:

“The first benefits of oral GLP-1 medicines are that they’re simpler to take, transport, and retailer. They’re additionally sometimes cheaper to fabricate, which might result in decrease prices for sufferers. The disadvantages are that they’re barely much less efficient than injections and require each day as a substitute of weekly administration.”

Novo Nordisk additionally outlined pricing preparations they recommend will enhance entry to the Ozempic tablet. For insured people, the treatment could also be obtainable for $25 for as much as a 3-month provide.

Self-pay choices, obtainable by means of Novo Nordisk’s pharmacy and choose telehealth suppliers, are anticipated to vary from roughly $149 to $299 per thirty days, relying on dose energy, defining a month’s provide as one bottle of 30 capsules.

This may increasingly supply a less expensive various to injectable Ozempic, as whereas a 3-month provide might also be obtainable for $25, self-pay sufferers can expect to pay $349 per thirty days for doses as much as 1 mg and $499 for the two mg dose.

“Pricing and insurance coverage protection are important components in treatment adherence,” Ali advised MNT.

“Excessive out-of-pocket bills make sufferers much less more likely to search or preserve remedy. Consequently, if prices stay excessive, people in decrease socioeconomic areas with restricted well being protection will face important boundaries to accessing these medicines,” he added.

The rebrand of the Ozempic tablet could replicate a broader shift in diabetes care towards GLP-1–based mostly therapies, with the FDA approving Foundayo, an oral GLP-1 receptor agonist from Eli Lily, in April 2026.

Whereas GLP-1-based therapies have historically been administered by way of injection, the oral formulations goal to offer a extra handy various for individuals who want to not use injectable medicines.

Novo Nordisk provides that the tablet is manufactured end-to-end within the U.S. and shall be extensively distributed by means of established pharmacy networks. In addition they be aware that that is the primary time oral semaglutide for sort 2 diabetes is being provided by means of their direct-to-patient service.

“Accessibility is essential, particularly as these medicines are in excessive demand and have confronted shortages,” Ali highlights. “Lack of entry typically leads sufferers to change to much less efficient alternate options or discontinue remedy completely.”

Past blood sugar management, Novo Nordisk additionally states that the Ozempic tablet can also be accepted for lowering the danger of main cardiovascular occasions, together with heart attack, stroke, or loss of life, in adults with sort 2 diabetes who’re at elevated threat.

“Actual-world cardiovascular advantages are linked to weight reduction, improved blood stress, and lowered irritation,” Ali notes. “Some research have proven a discount in main adversarial cardiovascular occasions by 18-20%. Sufferers with diabetes, weight problems, and current atherosclerotic heart problems stand to profit essentially the most.”